Skip to main content
SpringerLink
Log in

Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Turkington R.W., Underwood L.E., Van Wyk J.J. Elevated serum prolactin levels after pituitary stalk section in man. N. Engl. J. Med. 285: 707, 1971.

    PubMed  CAS  Google Scholar 

  2. Page R.B., Bergland R.M. Pituitary vasculature. In: Allen M.B. Jr., Mahesh V. (Eds.), The pituitary. A current review. Academic Press, New York, 1977, p. 9.

    Google Scholar 

  3. Schally A.V., Bowers C.Y., Redding T.W., Barrett J.F. Isolation ot thyrotropin releasing factor (TRF) from porcine hypothalamus. Biochem. Biophys. Res. Commun. 25: 165, 1966.

    PubMed  CAS  Google Scholar 

  4. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77, 1973.

    PubMed  CAS  Google Scholar 

  5. Schally A.V., Arimura A., Baba Y., Nair R.M.G., Matsuo H., Redding T.W., Debeljuk L., White W.R. Isolation and properties of the FSH and LH releasing hormone. Biochem. Biophys. Res. Commun. 43: 393, 1971.

    PubMed  CAS  Google Scholar 

  6. Brownstein M., Palkovits M., Saavedra J.M., Bassiri R.M., Utiger R.D. Thyrotropin releasing hormone in specific nuclei of the brain. Science 185: 267, 1974.

    PubMed  CAS  Google Scholar 

  7. Arimura A., Sato W., Dupont A., Nishi N., Schally A.V. Abundance of immunoreactive growth hormone-release inhibiting hormone in the stomach and the pancreas of the rat. Fed. Proc. 34: 273, 1975.

    Google Scholar 

  8. Arimura A., Sato W., Kumasaka T., Worobec R.B., Debeljuk L., Dunn J., Schally A.V. Production of antiserum to LH releasing hormone (LH-RH) associated with gonadal atrophy in rabbits: development of radioimmunoassays for LH-RH. Endocrinology 93: 1092, 1973.

    PubMed  CAS  Google Scholar 

  9. Wilber J.F., Seibel M.J. Thyrotropin releasing hormone interactions with an anterior pituitary membrane receptor. Endocrinology 92: 888, 1973.

    PubMed  CAS  Google Scholar 

  10. Grant G., Vale W., Guillemin R. Characteristics of the pituitary binding sites of thyrotropin releasing factor. Endocrinology 92: 1629, 1973.

    PubMed  CAS  Google Scholar 

  11. Labrie F., Borgeat P., Ferland L., Lemay A., Dupont A., Lemaire S., Pelletier G., Barden N., Drouin J., De Lean A., Belanger A., Jolicoeur P. Mechanism of action and modulation of activity of hypothalamic hypophysiotropic hormones. In: Motta M., Crosignani P.G., Martini L. (Eds.), Hypothalamic hormones. Academic Press, London, 1975, p. 109.

    Google Scholar 

  12. Eskay R.L., Oliver C., Ben-Jonathan N., Porter J.C. Hypothalamic hormones in portal and systemic blood. In: Motta M., Crosignani P.G., Martini L. (Eds.), Hypothalamic hormones. Academic Press, London, 1975, p. 125.

    Google Scholar 

  13. Seyler L.E. Jr., Reichlin S. Luteinizing hormone-releasing factors (LRF) in plasma of post-menopausal women. J. Clin. Endocrinol. Metab. 37: 197, 1973.

    PubMed  CAS  Google Scholar 

  14. Eskay R.L., Mical R.S., Porter J.C. Relationship between luteinising hormone releasing hormone concentration in hypophysial portal blood and luteinising hormone release in intact, castrated and electrochemically-stimulated rats. Endocrinology 100: 263, 1977.

    PubMed  CAS  Google Scholar 

  15. Lien E.L., Fenichel R.L., Garsky V., Sarantakis D., Grant N.H. Encephalin stimulated prolactin release. Life Sci. 19: 837, 1976.

    PubMed  CAS  Google Scholar 

  16. Ferland L., Fuxe R., Eneroth P., Gustafsson J.A., Skett P. Effects of methionine-encephalin on prolactin release and catecholamine levels and turnover in the median eminence. Eur. J. Pharmacol. 43: 89, 1977.

    PubMed  CAS  Google Scholar 

  17. Cusan L., Dupont A., Kledzik G.S., Labrie F., Coy D.H., Schally A.V. Potent prolactin and growth hormone releasing activity of more analogues of met-encephalin. Nature 268: 544, 1977.

    PubMed  CAS  Google Scholar 

  18. Kato Y., Chihara K., Ohgo S., Iwasaki Y., Abe H., Imura H. Growth hormone and prolactin release by substance P in rats. Life Sci. 19: 441, 1976.

    PubMed  CAS  Google Scholar 

  19. Von Graffenried B., Del Pozo E., Roubicek H., Krebs E., Poldinger W., Burmeister P., Kerp L. Effects of the synthetic encephalin analogue FK 33–824 in man. Nature 272: 729, 1978.

    Google Scholar 

  20. Said S.I., Porter J.C. Vasoactive intestinal peptide (VIP): evidence for secretion in hypothalamic portal blood. Fed. Proc. 37: 482, 1978.

    Google Scholar 

  21. Krulich L., Dhariwal A.P.S., McCann S.M. Stimulatory and inhibitory effectsof purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 83: 783, 1968.

    PubMed  CAS  Google Scholar 

  22. Valverde R.C., Chieffo V., Reichlin S. Prolactin releasing factor in porcine and rat hypothalamic tissue. Endocrinology 91: 982, 1972.

    PubMed  CAS  Google Scholar 

  23. Guillemin R., Hearn W.R., Cheek W.R., Householder D.E. Control of corticotrophin release: further studies with in vitro methods. Endocrinology 60: 488, 1957.

    PubMed  CAS  Google Scholar 

  24. Fuxe K., Hokfelt T. Catecholamines in the hypothalamus and pituitary gland. In: Ganong W., Martini L., (Eds.), Frontiers in neuroendocrinology. Oxford University Press, New York, 1969, p. 47.

    Google Scholar 

  25. Ben-Jonathan N., Oliver C., Weiner H.J., Mical R.S., Porter J.C. Dopamine in hypophysial portal plasma of the rat during the oestrus cycle and throughout pregnancy. Endocrinology 100: 452, 1977.

    PubMed  CAS  Google Scholar 

  26. Burrow G.N., May P.B., Spaulding S.W., Donabedian R.K. TRH and dopamine interactions affecting pituitary hormone secretion. J. Clin. Endocrinol. Metab. 45: 65, 1977.

    PubMed  CAS  Google Scholar 

  27. Besses G.S., Burrow G.N., Spaulding S.W., Donabedian R.K. Dopamine infusionacutely inhibits the TSH and prolactin response to TRH. J. Clin. Endocrinol. Metab. 41: 985, 1975.

    PubMed  CAS  Google Scholar 

  28. Leebaw W.F., Lee L.A., Woolf P.D. Dopamine affects basal and augmented pituitary hormone secretion. J. Clin. Endocrinol. Metab. 47: 480, 1978.

    PubMed  CAS  Google Scholar 

  29. Leblanc H.G., Lachelin C.L., Abu-Fadil S., Yen S.S.C. Effects of dopamine infusion on pituitary secretion in humans. J. Clin. Endocrinol. Metab. 44: 728, 1977.

    PubMed  Google Scholar 

  30. Oldendorf W.H. Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection. Am. J. Physiol. 221: 1629, 1971.

    PubMed  CAS  Google Scholar 

  31. Weil-Malherbe H., Whitby L.G., Axelrod J. The uptake of circulating 3-H norepinephrine by the pituitary gland and various areas of the brain. J. Neurochem. 8: 55, 1961.

    PubMed  CAS  Google Scholar 

  32. Dobbing J. The blood-brain barrier. Physiol. Rev. 41: 130, 1961.

    PubMed  CAS  Google Scholar 

  33. Brown G.M., Seeman P., Lee T. Dopamine/ neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology 99: 1407, 1976.

    PubMed  CAS  Google Scholar 

  34. Caron M.G., Beaulieu M., Raymond V., Gagne B., Drouin J., Lefkowitz R.J., Labrie F. Dopaminergic receptors in the anterior pituitary gland. J. Biol. Chem. 253: 2244, 1978.

    PubMed  CAS  Google Scholar 

  35. Yeo T., Thorner M.O., Jones A., Lowry P.J., Besser G.M. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Clin. Endocrinol. (Oxf.) 10: 123, 1979.

    CAS  Google Scholar 

  36. MacLeod R.M., Lehmeyer J.D. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94: 1077, 1974.

    PubMed  CAS  Google Scholar 

  37. Martin J.B. Neural regulation of growth hormone secretion. N. Engl. J. Med. 288: 1384, 1973.

    PubMed  CAS  Google Scholar 

  38. Lamberts S.W.J., MacLeod R.M. Effects of cyproheptadine on prolactin synthesis and release by normal and suppressed pituitary glands and by dispersed pituitary tumour cells. Endocrinology 103: 1710, 1978.

    PubMed  CAS  Google Scholar 

  39. Oliver C., Mical R.S., Porter J.C. Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology 101: 598, 1977.

    PubMed  CAS  Google Scholar 

  40. Lamberts S.W.J., MacLeod R.M. The interaction of the serotoninergic and dopaminergic systems on prolactin secretion in the rat. Endocrinology 103: 287, 1978.

    PubMed  CAS  Google Scholar 

  41. MacLeod R.M., Lamberts S.W.J. The biphasic regulation of prolactin secretion by dopamine agonists-antagonists. Endocrinology 103: 200, 1978.

    Google Scholar 

  42. Daughaday W.H., Hall K., Raben M.S., Salmon W.D. Jr., Van den Brande J.L., Van Wyk J.J. Somatomedin: proposed designation for sulphation factor. Nature 235: 107, 1972.

    PubMed  CAS  Google Scholar 

  43. Daughaday A.J., Herington A.C., Phillips, L.S. The regulation of growth by endocrines. Ann. Rev. Physiol. 37: 211, 1975.

    CAS  Google Scholar 

  44. Laron Z., Pertzeland A., Karp M., Kowaldo-Silber-Geld A., Daughaday W.H. Administration of GH to patients with familial dwarfism with raised plasma immunoreactive GH: measurement of sulfation factors, metabolic and linear growth responses. J. Clin. Endocrinol. Metab. 33: 332, 1971.

    PubMed  CAS  Google Scholar 

  45. Coy D.H., Coy E.J., Arimura A., Schally A.V. Solid phase synthesis of growth hormone release inhibiting factor. Biochem. Biophys. Res. Commun. 54: 1267, 1973.

    PubMed  CAS  Google Scholar 

  46. Schally A.V., Dupont A., Arimura A., Redding T.W., Nishi M., Linthicum G.L., Schlesinger D.H. Isolation and structures of somatostatin from porcine hypothalami. Biochemistry 15: 509, 1976.

    PubMed  CAS  Google Scholar 

  47. Redding T.W., Coy D.H. The disappearance, distribution and excretion of I25I-tyrosine-l-growth hormone-releasing inhibiting hormone in mice, rats and man. 56 th meeting of the American Endocrine Society, Atlanta, Georgia, June 12–24, 1974, abstract 198.

    Google Scholar 

  48. Gerich J.E., Raptis S., Rosenthal J. Somatostatin symposium. Metabolism 27: suppl. 1, 1978.

    Google Scholar 

  49. Snow M.H., Scanion M.F., Mora B., Heath M., Hall R., Gomez-Pan A. Pituitary actions of somatostatin. Ann. Clin. Res. 10: 145, 1978.

    PubMed  CAS  Google Scholar 

  50. Arimura A., Smith W.D., Schally A.V. Blockade of the stress-induced decrease in blood GH by antisomatostatin serum in rats. Endocrinology 98: 540, 1976.

    PubMed  CAS  Google Scholar 

  51. Terry L.C., Willoughby J.O., Brazeau P. Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat. Science 192: 565, 1976.

    PubMed  CAS  Google Scholar 

  52. Tannenbaum G.S., Epelbaum J., Colle E., Brazeau P., Martin J.B. Dissociation of effects of somatostatin antiserum on growth hormone and insulin secretion. Metabolism 27: suppl. 1, 1263, 1978.

    PubMed  CAS  Google Scholar 

  53. Abrams R.L., Grumbach M.M., Kaplan S.L. The effect of administration of HGH on the plasma GH, Cortisol, glucose and FFA response to insulin. Evidence for GH autoregulation in man. J. Clin. Invest. 50: 940, 1971.

    PubMed Central  PubMed  CAS  Google Scholar 

  54. Baker B.L., Yen Y.Y. The influence of hypophysectomy on the stores of somatostatin in the hypothalamus and pituitary stem. Proc. Soc. Exp. Biol. Med. 151: 599, 1976.

    PubMed  CAS  Google Scholar 

  55. Lal S., Delavega C.S., Sourkes T.L., Friesen H.G. Effects of apomorphine on GH, PRL, LH and FSH levels in human serum. J. Clin. Endocrinol. Metab. 37: 719, 1973.

    PubMed  CAS  Google Scholar 

  56. Maany I., Frazer A., Mendels J. Apomorphine: effect on GH. J. Clin. Endocrinol. Metab. 40: 162, 1975.

    PubMed  CAS  Google Scholar 

  57. Camanni F., Massara F., Belforte L., Molinatti G.M. Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine. J. Clin. Endocrinol. Metab. 40: 363, 1975.

    PubMed  CAS  Google Scholar 

  58. Thorner M.O., Wass H.A.H., Jones A., Bloom S.R., Mac Leod R.M. Effect of piribedil infusions on circulating growth hormone (GH), insulin, glucagon, Cortisol and blood sugar in man. Proceedings of the Vth International Congress of Endocrinology, Hamburg, 1976, abstract 59.

    Google Scholar 

  59. Boyd A.E., Lebovitz H.E., Pfeiffer J.B. Stimulation of human-growth-hormone secretion by L-dopa. N.Engl. J. Med. 283: 1425, 1970.

    PubMed  Google Scholar 

  60. Eddy R.L., Jones Lloyd A., Chakmakjan Z.H., Silverthorne M.C. Effect of levo-dopa (L-dopa) on human hypophysial tropic hormone release. J. Clin. Endocrinol. Metab. 33: 709, 1971.

    PubMed  CAS  Google Scholar 

  61. Lal S., Guyda H., Bikadoroff S. Effect of methysergide and pimozide on apomorphine induced growth hormone secretion in man. J. Clin. Endocrinol. Metab. 44: 766, 1977.

    PubMed  CAS  Google Scholar 

  62. Dammacco F., Rigillo N., Tafaro E., Gagliardi F., Ohetri G., Dammacco A. Effects of 2-bromo-α-ergocryptine and pimozide on growth hormone secretion in man. Horm. Metab. Res. 8: 247, 1976.

    PubMed  CAS  Google Scholar 

  63. Masala A., Delitala G., Alagna S., Devilla L. Effect of pimozide on levodopa-induced growth hormone release in man. Clin. Endocrinol. (Oxf.) 7: 253, 1977.

    CAS  Google Scholar 

  64. Verde G., Oppizzi G., Colussi G., Cremascoli G., Botalla L., Muller E.E., Silvestrini F., Chiodini P.G., Liuzzi A. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in acromegalic patients. Clin. Endocrinol. (Oxf.) 5: 419, 1976.

    CAS  Google Scholar 

  65. MacLeod R.M. Influence of norepinephrine and catecholamine depleting agents on the synthesis and release of prolactin and growth hormone. Endocrinology 85: 916, 1969.

    PubMed  CAS  Google Scholar 

  66. MacLeod R.M., Fontham E.M., Lehmeyer J.E. Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines. Neuroendocrinology 6: 283, 1970.

    PubMed  CAS  Google Scholar 

  67. Birge C.A., Jacobs L.S., Hammer C.T., Daughaday W.H. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophysis. Endocrinology 86: 120, 1970.

    PubMed  CAS  Google Scholar 

  68. Smythe G.A., Compton P.J., Lazarus L. Serotoninergic control of human growth hormone secretion: the actions of L-dopa and 2-bromo-α-ergocryptine. In: Pecile A., Muller E.E. (Eds.), Growth hormone and related peptides. Excerpta Medica, Amsterdam, 1976, p. 222.

    Google Scholar 

  69. Smythe G.A., Lazarus L. Blockade of the dopamine-inhibitory control of prolactin secretion in rats by 3,4-dimethoxyphenylethyl alanine (3,4-di-O-methyldopamine). Endocrinology 93: 147, 1973.

    PubMed  CAS  Google Scholar 

  70. Smythe G.A., Lazarus L. Growth hormone regulation by melatonin and serotonin. Nature 244: 230, 1973.

    PubMed  CAS  Google Scholar 

  71. Karobath M., Diaz J.L., Huttunen M. Serotonin synthesis by rat brain synaptosomes. Effects of L-dopa, L-3-methoxytyrosine and catecholamines. Biochem. Pharmacol. 21: 1245, 1972.

    PubMed  CAS  Google Scholar 

  72. Goodwin F.K., Dunner D.L., Gershon E.S. Effect of L-dopa treatment on brain serotonin metabolism in depressed patients. Life Sci. 10: 751, 1971.

    CAS  Google Scholar 

  73. Camanni F., Massara F., Belforte L., Rosatello A., Molinatti G.M. Prolactin levels in normal and acromegalic subjects. J. Clin. Endocrinol. Metab. 44: 465, 1977.

    PubMed  CAS  Google Scholar 

  74. Cohen H.N., Hay I.D., Beastall G.H., Thomson J.A. Metoclopramide induced growth hormone release in hypogonadal males. Clin. Endocrinol. (Oxf.) 11: 95, 1979

    CAS  Google Scholar 

  75. Cohen H.N., Hay I.D., Thomson J.A., Logue F., Ratcliffe W.A., Beastall G.H. Metoclopramide stimulation: a test of growth hormone reserve in adolescent males. Clin. Endocrinol. (Oxf.) 11: 89, 1979.

    CAS  Google Scholar 

  76. Schwinn G., Heckrodt B., Kobberling J. The effect of pimozide, TRH and cyproheptadine on sleep-induced growth hormone secretion in man. Acta Endocrinol. (Kbh.) 87: 11, 1978.

    Google Scholar 

  77. Schwinn G., Schwarck H., Mclntoch C., Milstrey H.R., Willms B., Kobberling J. Effect of the dopamine receptor blocking agent pimozide on the growth hormone response to arginine and exercise and on the spontaneous growth hormone fluctuations. J. Clin. Endocrinol. Metab. 43: 1183, 1976.

    PubMed  CAS  Google Scholar 

  78. Blackard W.G., Heidingsfelder S.A. Adrenergic receptor control mechanism for growth hormone secretion. J. Clin. Invest. 47: 1407, 1968.

    PubMed Central  PubMed  CAS  Google Scholar 

  79. Lal S., Tolis G., Martin J.B., Brown G.M., Guyda H., Effect of Clonidine on growth hormone, prolactin, luteinising hormone, follicle stimulating hormone and thyroid stimulating hormone in the serum of normal man. J. Clin. Endocrinol. Metab. 41: 827, 1975.

    PubMed  CAS  Google Scholar 

  80. Parra A., Schultz R.B., Foley T.P. Jr., Blizzard R.M. Influence of epinephrine-propranolol infusion on growth hormone release in normal and hypopituitary patients. J. Clin. Endocrinol. Metab. 30: 134, 1970.

    PubMed  CAS  Google Scholar 

  81. Kansal P.C., Buse J., Talbert O.R., Buse M. The effect of L-dopa on plasma growth hormone, insulin and thyroxine. J. Clin. Endocrinol. Metab. 34: 99, 1972.

    PubMed  CAS  Google Scholar 

  82. Massara F., Camanni F. Effects of various adrenergic receptor stimulating and blocking agents on HGH secretion. J. Endocrinol. 54: 195, 1972.

    PubMed  CAS  Google Scholar 

  83. Martin J.P., Mead P., Kontor J. Plasma GH responses to hypothalamic hippocampal and amygdaloid electrical stimulation: effects of variation in stimulus parameters and treatment with α-methyl-p-tyrosine (α-mt). Endocrinology 92: 1354, 1973.

    PubMed  CAS  Google Scholar 

  84. Martin J.B., Tannenbaum G., Willoughby J.D., Renaud L.P., Brazeau P. Functions of the central nervous system in regulation of pituitary GH secretion. In: Motta M., Crosignani P.G., Martini L. (Eds.), Hypothalamic hormones. Academic Press, London, 1975, p. 217.

    Google Scholar 

  85. Imura H., Nakai Y., Yoshima T. Effect of 5-hydroxy-tryptophan on growth hormone and ACTH release in man. J. Clin. Endocrinol. Metab. 36: 204, 1973.

    PubMed  CAS  Google Scholar 

  86. Woolf P.D., Lee L. Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion. J. Clin. Endocrinol. Metab. 45: 123, 1977.

    PubMed  CAS  Google Scholar 

  87. Lancranjan I., Wirz-Justice A., Puhringer W., Del Pozo E. Effect of 1–5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man. J. Clin. Endocrinol. Metab. 45: 588, 1977.

    PubMed  CAS  Google Scholar 

  88. Jacoby J.H., Greenstein M., Sassin J.F., Weitzman E.D. Effects of monoamine precursors on the release of GH in the Rhesus monkey. Neuroendocrinology 14: 95, 1974.

    PubMed  CAS  Google Scholar 

  89. Mendelson W.B., Jacobs L.S., Reichman J.D., Othmer E., Cryer P.E., Daughaday W.H. Methysergide. Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion. J. Clin. Invest. 56: 690, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  90. Bivens L.H., Lebovitz H.E., Feldman J.M. Inhibition of hypoglycaemia induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide. N. Engl. J. Med. 289: 236, 1973.

    PubMed  CAS  Google Scholar 

  91. Smythe G.A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. J. Clin. Invest. 54: 116, 1974.

    PubMed Central  PubMed  CAS  Google Scholar 

  92. Smythe G.A. The role of serotonin and dopamine in hypothalamicpituitary function. Clin. Endocrinol. (Oxf.) 7: 325, 1977.

    CAS  Google Scholar 

  93. Rivier C., Vale W., Ling N., Brown M., Guillemin R. Stimulation in vivo of the secretion of prolactin and GH by β-endorphin. Endocrinology 100: 238, 1977.

    PubMed  CAS  Google Scholar 

  94. Chihara K., Arimura A., Coy D.H., Schally A.V. Studies on the interaction of endorphins, substance P and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology 102: 281, 1978.

    PubMed  CAS  Google Scholar 

  95. Stubbs W.A., Delitala G., Jones A., Jeffcoate W.J., Ed-wards C.R.W., Ratter S.J., Besser G.M., Bloom S.R., Alberti K.G.M.M. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225, 1978.

    PubMed  CAS  Google Scholar 

  96. Maeda K., Kato Y., Chihara K., Ohgo S., Iwasaki Y., Abe H., Imura H. Suppression by thyrotrophin-releasing hormone (TRH) of growth hormone release induced by arginine and insulin-induced hypoglycaemia in man. J. Clin. Endocrinol. Metab. 43: 453, 1976.

    PubMed  CAS  Google Scholar 

  97. Maeda K., Kato Y., Chihara K., Ohgo S., Iwasaki Y., Imura H. Suppression by TRH.of HGH release induced by L-dopa. J. Clin. Endocrinol. Metab. 41: 408, 1975.

    PubMed  CAS  Google Scholar 

  98. Mayer G., Schwinn G. Exercise-induced growth hormone release. Suppression by TRH and augmentation by bromocriptine. Acta Endocrinol. (Kbh.) 87: 10, 1978.

    Google Scholar 

  99. Irie M., Tsushima T.J. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J. Clin. Endocrinol. Metab. 35: 97, 1972.

    PubMed  CAS  Google Scholar 

  100. Faglia G., Beck-Pecoz P., Ferrari C., Travaglini P., Ambrosi B. Plasma growth hormone response to thyrotropin releasing hormone in patients with active acromegaly. J. Clin. Endocrinol. Metab. 36: 1259, 1973.

    PubMed  CAS  Google Scholar 

  101. Rubin A.L., Levin R.S., Bernstein R.I., Tyrrel J.B., Noacco C., Forsham P.H. Stimulation of growth hormone by luteinising hormone-releasing hormone in active acromegaly. J. Clin. Endocrinol. Metab. 37: 160, 1973.

    PubMed  CAS  Google Scholar 

  102. Beck P., Parker M.L., Daughaday W.H. Paradoxical hypersecretion of growth hormone in response to glucose. J. Clin. Endocrinol. Metab. 26: 463, 1966.

    PubMed  CAS  Google Scholar 

  103. Collu R., Leboeuf G., Letarte J., Ducharme J.R. Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism. J. Clin. Endocrinol. Metab. 44: 743, 1977.

    PubMed  CAS  Google Scholar 

  104. Gomez-Pan A., Scanlon M.F., Thorner M.O., Rees L.H., Schally A.V., Hall R., Besser G.M. Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome. Clin. Endocrinol. (Oxf.), 10: 575, 1979.

    CAS  Google Scholar 

  105. Maeda K., Kato Y., Yamaguchi N., Chihara K., Ohgo S., Iwasaki Y., Yoshimoto Y., Moridera K., Kuromaru S., Imura H. Growth hormone release following thyrotropin-releasing hormone injections into patients with anorexia nervosa. Acta Endocrinol. (Kbh.) 81: 1, 1976.

    CAS  Google Scholar 

  106. Maeda K., Kato T., Ohgo S., Chihara K., Yoshimoto Y., Yamaguchi N., Kuromaru S., Imura I. Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression. J. Clin. Endocrinol. Metab. 40: 501, 1975.

    PubMed  CAS  Google Scholar 

  107. Podolsky S., Leopold N.A. Growth hormone abnormalities in Huntington’s chorea. Effect of L-dopa administration. J. Clin. Endocrinol. Metab. 39: 36, 1974.

    PubMed  CAS  Google Scholar 

  108. Panerai A.E., Salerno F., Manneschi M., Cocchi D., Muller E.E. Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease. J. Clin. Endocrinol. Metab. 45: 134, 1977.

    PubMed  CAS  Google Scholar 

  109. Zanoboni A., Zanoboni-Muciaccia W. Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis. J. Clin. Endocrinol. Metab. 45: 576, 1977.

    PubMed  CAS  Google Scholar 

  110. Becker M.D., Cook G.C., Wright A.D. Paradoxical elevation of growth hormone in active chronic hepatitis. Lancet 2: 1035, 1969.

    PubMed  CAS  Google Scholar 

  111. Gonzalez-Barcena D., Kastin A.J., Schalch D.S., Torres-Zamora M., Perez-Pasten E., Kato A., Schally A.V. Responses to thyrotropin releasing hormone in patients with renal failure and after infusion in normal men. J. Clin. Endocrinol. Metab. 36: 117, 1973.

    PubMed  CAS  Google Scholar 

  112. Udeschini G., Cocchi D., Panerai A.E., Gil-Ad I., Rossi G.I., Chiodini P.G., Liuzzi A., Muller E.E. Stimulation of growth hormone release by thyrotropin-releasing hormone in the hypophysectomised rat bearing an ectopic pituitary. Endocrinology 98: 807, 1976.

    PubMed  CAS  Google Scholar 

  113. Panerai A.E., Gil-Ad I., Cocchi D., Locatelli V., Rossi G.L., Muller E.E. Thyrotrophin releasing hormone-induced growth hormone and prolactin release: physiological studies in intact rats and in hypophysectomised rats bearing an ectopic pituitary gland. J. Endocrinol. 72: 301, 1977.

    PubMed  CAS  Google Scholar 

  114. Panerai A.E., Cocchi D., Gil-Ad I., Locatelli V., Rossi G.L., Muller E.E. Stimulation of growth hormone release by luteinising hormone-releasing hormone and melanocyte-stimulating hormone-release inhibiting hormone in the hypophysectomised rat bearing an ectopic pituitary. Clin. Endocrinol. (Oxf.) 5: 717, 1976.

    CAS  Google Scholar 

  115. Muller E.E., Panerai A.E., Cocchi D., Gil-Ad I., Olgiati V.R. Nonspecific release of GH by hypothalamic neurohormones following experimental interruption of central nervous system (C.N.S.)-anterior pituitary (AP) connections. 58th Annual Meeting of the Endocrine Society, San Francisco, 1976, abstract 127.

    Google Scholar 

  116. Hoyte K.M., Martin J.B. Recovery from paradoxical growth hormone response in acromegaly after transphenoidal selective adenomectomy. J. Clin. Endocrinol. Metab. 41: 656, 1975.

    PubMed  CAS  Google Scholar 

  117. Takahara J., Yakushiji W., Yamauchi J., Miyoshi M., Hisogi H., Ofuji T. Transient appearance of a provocative growth hormone response to L-dopa following incomplete adenomectomy in an acromegalic patient. J. Clin. Endocrinol. Metab. 44: 599, 1977.

    PubMed  CAS  Google Scholar 

  118. Ishibashi M., Yamaji T., Kosaka K. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients. J. Clin. Endocrinol. Metab. 45: 275, 1977.

    PubMed  CAS  Google Scholar 

  119. Gomez-Pan A., Tunbridge W.M.G., Duns A., Hall R., Besser G.M., Coy D.H., Schally A.V., Kastin A.J. Hypothalamic hormone interaction in acromegaly. Clin. Endocrinol. (Oxf.) 4: 455, 1975.

    CAS  Google Scholar 

  120. Matsukura S., Kakita T., Hirata Y., Yoshimi H., Fukase M., Iwasaki Y., Kato Y., Imura H. Adenylate cyclase of GH and ACTH producing tumours of human: activation by non-specific hormones and other bioactive substances. J. Clin. Endocrinol. Metab. 44: 392, 1977.

    PubMed  CAS  Google Scholar 

  121. Cavagnini F., Invitti C., Di Landro A., Tenconi L., Maraschini C., Girotti G. Effects of a gamma aminobutyric acid (GABA) derivative, Baclofen. J. Clin. Endocrinol. Metab. 45: 579, 1977.

    PubMed  CAS  Google Scholar 

  122. Pontiroli A.E., Viberti G., Vicari A., Pozza G. Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycaemia. J. Clin. Endocrinol. Metab. 43: 582, 1976.

    PubMed  CAS  Google Scholar 

  123. Jacobs L.S., Sneid D.S., Garland J.T., Laron Z., Daughaday W.H. Receptor-active growth hormone in Laron dwarfism. J. Clin. Endocrinol. Metab. 42: 403, 1976.

    PubMed  CAS  Google Scholar 

  124. Casanueva F., Bett R., Frigerio C., Cocchi D., Muller E.E. Growth hormone-releasing effect of an enkephalin analogue (D.A.M.E) in the dog: evidence for a cholinergic mediation. 1 st International meeting of Neuroendocrinology Barcelona, 1979, abstract p. 11.

    Google Scholar 

  125. Chiodini P.G., Liuzzi A., Botalla L., Cremascoli G., Silvestrini F. Inhibitory effect of dopaminergic stimulation on GH release in acromegaly. J. Clin. Endocrinol. Metab. 38: 200, 1974.

    PubMed  CAS  Google Scholar 

  126. Liuzzi A., Chiodini P.G., Botalla L., Cremascoli G., Muller E.E. Silvestrini F. Decreased plasma growth hormone (hGH) levels in acromegalics following CB 154 (2-Br-α-erg) administration. J. Clin. Endocrinol. Metab. 38: 910, 1974.

    PubMed  CAS  Google Scholar 

  127. Camanni F., Massara F., Fassio U., Molinatti G.M., Muller E.E. Effect of five dopaminergic drugs on plasma hGH levels in acromegalic subjects. Neuroendocrinology 19: 227, 1975.

    PubMed  CAS  Google Scholar 

  128. Chiodini P.G., Liuzzi A., Muller E.E., Totalla L., Cremascoli G., Oppizi G., Verde G., Silvestrini F. Inhibitory effects of an ergoline derivative, methergoline, on GH and prolactin levels. J. Clin. Endocrinol. Metab. 43: 356, 1976.

    PubMed  CAS  Google Scholar 

  129. Sachdev Y., Gomez-Pan A., Tunbridge W.M.G., Duns A., Weightman D.R., Hall R., Goolamali S.K. Bromocriptine therapy in acromegaly. Lancet 2: 1164, 1975.

    PubMed  CAS  Google Scholar 

  130. Thorner M.O., Chait A., Aitken M., Benker G., Bloom S.R., Mortimer C.H., Sanders P., Stuart Mason A., Besser G.M. Successful treatment of acromegaly with bromocriptine. Br. Med. J. 1: 299, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  131. Delitala G., Masala A., Alagna S., Devilla L. Adverse effect of metoclopramide on growth hormone inhibition induced by bromocriptine in acromegaly. IRCS J. Med. Sci. 4: 290, 1976.

    CAS  Google Scholar 

  132. Mashiter K., Adams E., Beard M., Holley A. Bromocriptine inhibits prolactin and growth hormone release by human pituitary tumours in culture. Lancet 2: 197, 1977.

    PubMed  CAS  Google Scholar 

  133. Camanni F., Picotti G.B., Massara F., Molinatti G.M., Mantegazza P., Muller E.E. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients. J. Clin. Endocrinol. Metab. 47: 647, 1978.

    PubMed  CAS  Google Scholar 

  134. Conrenblum B., Sirek A.M.T., Horvath E., Kovacs K., Ezrin C. Human mixed somatotrophic and lactotrophic pituitary adenomas. J. Clin. Endocrinol. Metab. 42: 857, 1976.

    Google Scholar 

  135. Greer M.A. Evidence of hypothalamic control of the pituitary release of thyrotrophin. Proc. Soc. Exp. Biol. Med. 77: 603, 1951.

    PubMed  CAS  Google Scholar 

  136. Folkers K., Enzman F., Boler J., Bowers C.Y., Schally A.V. Discovery of modification of the synthetic tripeptide sequence of the thyrotropin releasing hormone having activity. Bioch. Biophys. Res. Commun. 37: 123, 1969.

    CAS  Google Scholar 

  137. Burgus R., Dunn T.F., Desiderio D., Ward D.N., Vale W., Guillemin R. Characterisation of the hypothalamic-hypophysiotropic TSH-releasing factor (TRF) of ovine origin. Nature 226: 321, 1970.

    PubMed  CAS  Google Scholar 

  138. Scanion M.F., Rees Smith B., Hall R. Thyroid-stimulating hormone: neuroregulation and clinical applications. Clin. Sci. Mol. Med. 55: 1, 129, 1978.

    Google Scholar 

  139. Burger H.G., Patel Y.C. TSH and TRH: their physiological regulation and the clinical applications of TRH. In: Martini L., Besser G.M. (Eds.), Clinical Neuroendocrinology. Academic Press, New York, 1977, p. 67.

    Google Scholar 

  140. Annunziato L., Di Renzo G., Lombardi G., Scopacasa F., Schettini G., Preziosi P., Scapagnini U. The role of central noradrenergic neurons in the control of thyrotropin secretion in the rat. Endocrinology 100: 738, 1977.

    PubMed  CAS  Google Scholar 

  141. Tuomisto J., Ranta T., Mannisto P., Saarinen A., Leppaluoto J. Neurotransmitter control of thyrotropin secretion in the rat. Eur. J. Pharmacol. 30: 221, 1975.

    PubMed  CAS  Google Scholar 

  142. Ranta T., Mannisto P., Tuomisto J. Evidence for dopaminergic control of thyrotrophin secretion in the rat. J. Endocrinol. 72: 329, 1977.

    PubMed  CAS  Google Scholar 

  143. Krulich L., Giachetti A., Marchlewska-Koj A., Hefco E., Jameson H.E. On the role of central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology 100: 496, 1977.

    PubMed  CAS  Google Scholar 

  144. Mannisto P.T., Ranta T. Neurotransmitter control of thyrotrophin secretion in hypothyroid rats. Acta Endocrinol. (Kbh.) 89: 100, 1978.

    CAS  Google Scholar 

  145. Chen H.J., Meites J. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology 96: 10, 1975.

    PubMed  CAS  Google Scholar 

  146. Grimm Y., Reichlin S. Thyrotropin releasing hormone (TRH): neurotransmitter regulation of secretion by mouse hypothalamic tissue in vitro. Endocrinology 93: 626, 1973.

    PubMed  CAS  Google Scholar 

  147. Mess B., Peter L. Effect of intra-cerebral serotonin administration on pituitary-thyroid function. Endocrinol. Exp. (Bratisl.) 9: 105, 1975.

    CAS  Google Scholar 

  148. Woolf P.D., Lee L.A., Schalch D.S. Adrenergic manipulation and thyrotrophin-releasing hormone (TRH)-induced thyrotropin (TSH) release. J. Clin. Endocrinol. Metab. 35: 616, 1972.

    PubMed  CAS  Google Scholar 

  149. Birk Lauridsen U., Faber J., Friis Th., Kirkegaard C., Nerup J. Thyrotropin (TSH) release during altered adrenergic α and β receptor influence. Horm. Met. Res. 8: 406, 1976.

    Google Scholar 

  150. Epstein S., Pimstone B.L., Vinik A.I., McLaren H. Failure of adrenergic α and β receptor blockade to elevate the TSH and prolactin response to TRH in hyperthyroidism. Clin. Endocrinol. (Oxf.) 4: 501, 1975.

    CAS  Google Scholar 

  151. Wartofsky L., Dimond R.C., Noel G.L., Frantz A.G., Earll J.M. Failure of propranolol to alter thyroid iodine release, thyroxine turnover, or the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. J. Clin. Endocrinol. Metab. 41: 485, 1975.

    PubMed  CAS  Google Scholar 

  152. Wiersinga W.M., Touber J.L. The influence of β-adrenoreceptor blocking agents on plasma thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 45: 293, 1977.

    PubMed  CAS  Google Scholar 

  153. Itoh S., Hiroshige T., Koseki T., Nakatsugawa T. Release of thyrotropin in relation to cold exposure. Fed. Proc. 25: 1187, 1966.

    PubMed  CAS  Google Scholar 

  154. Tuomisto J., Ranta T., Saarinen A., Mannisto P., Leppaluoto J. Neurotransmission and secretion of thyroid stimulating hormone. Lancet 2: 510, 1973.

    PubMed  CAS  Google Scholar 

  155. Fisher D.A., Odell W.D. Acute release of thyrotropin in the newborn. J. Clin. Invest. 48: 1670, 1969.

    PubMed Central  PubMed  CAS  Google Scholar 

  156. Odell W., Vanslager L., Bates R. Radioimmunoassay of human thyrotrophin. In: Hayes R.L., Goswitz F.A., Murphy B.E.P. (Eds.), Radioisotopes in medicine: in vitro studies. U.S. Atomic Energy Comm., Series no. 13: 185, 1968.

    Google Scholar 

  157. Tuomisto J., Mannisto P., Lamberg B.A., Linnoila M. Effect of cold exposure on serum thyrotrophm levels in man. Acta Endocrinol. (Kbh.) 83: 522, 1976.

    CAS  Google Scholar 

  158. Reichlin S. Control of thyrotropic hormone secretion. In: Martini L., Ganong W.F. (Eds.), Neuroendocrinology. Academic Press, New York, 1966, vol. 1, p. 445.

    CAS  Google Scholar 

  159. Emerson C.H., Utiger R.D. Plasma thyrotropin-releasing hormone concentration in the rat. Effect of thyroid excess and deficiency-and cold exposure. J. Clin. Invest. 56: 1564, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  160. Montoya E., Seibel M.J., Wilber J.F. Thyrotropin-releasing hormone secretory physiology: studies by radioimmunoassay and affinity chromatography. Endocrinology 96: 1413, 1975.

    PubMed  CAS  Google Scholar 

  161. Massara F., Camanni F., Vergano V., Belforte L., Molinatti G.M. Inhibition of thyrotropin and prolactin secretion by dopamine in man. J. Endocrinol. Invest. 1; 25, 1978.

    PubMed  CAS  Google Scholar 

  162. Spaulding S.W., Burrow G.N., Donabedian R., Van Woert M. L-dopa suppression of thyrotrophin releasing hormone response in man. J. Clin. Endocrinol. Metab. 35: 182, 1972.

    PubMed  CAS  Google Scholar 

  163. Miyai K., Onishi T., Hosokawa M., Ishibashi K., Kumahara Y. Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-α-ergocryptine. J. Clin. Endocrinol. Metab. 39: 391, 1974.

    Google Scholar 

  164. Felt V., Nedvidkova J. Effect of bromocriptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (hGH), thyroxine (T4) and triiodothyronine (T3) in hypothyroidism. Horm. Met. Res. 9: 274, 1977.

    CAS  Google Scholar 

  165. Yap P.L., Davidson N.M.D., Lidgard G.P., Fyffe J.A. Bromocriptine suppression of the thyrotropin response to thyrotropin releasing hormone. Clin. Endocrinol. (Oxf.) 9: 179, 1978.

    CAS  Google Scholar 

  166. Yoshimura M., Hachiya T., Ochi Y., Nagasaka A., Takeda A., Hidaka H., Refetoff S., Fang V.S. Suppression of elevated serum TSH levels in hypothyroidism by fusaric acid. J. Clin. Endocrinol. Metab. 45: 95, 1977.

    PubMed  CAS  Google Scholar 

  167. Delitala G., Masala A., Alagna S., Devilla L. Metoclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-α-ergocryptine (CB-154). IRCS Med. Sci. 3: 274, 1975.

    CAS  Google Scholar 

  168. Judd S.J., Lazarus L., Smythe G. Prolactin secretion by metoclopramide in man. J. Clin. Endocrinol. Metab. 43: 313, 1976.

    PubMed  CAS  Google Scholar 

  169. Onishi T., Miyai K., Izumi K., Nakanishi H., Kumahara Y. Prolactin response to chlorpromazine and thyrotropin-releasing hormone in hyperthyroidism. J. Clin. Endocrinol. Metab. 40: 30, 1975.

    PubMed  CAS  Google Scholar 

  170. L’Hermite M., Denayer P., Golstein J., Virasoro E., Vanhaelst L., Copinschi G., Robyn C. Acute endocrine profile of sulpiride in the human. Clin. Endocrinol. (Oxf.) 9: 195, 1978.

    Google Scholar 

  171. Scanlon M.F., Mora B., Shale D.J., Weightman D.R., Heath M., Snow M.H., Hall R. Evidence for dopaminergic control of thyrotrophin secretion in man. Lancet 2: 421, 1977.

    PubMed  CAS  Google Scholar 

  172. Scanlon M.F., Heath M., Mora B., Shale D., Snow M., Weightman D.R., Hall R. Inhibitory dopaminergic control of the release of thyroid-stimulating hormone in euthyroid and hypothyroid subjects. J. Endocrinol. 77: 31, 1978.

    Google Scholar 

  173. Scanlon M.F., Weightman D.R., Shale D.J., Mora B., Heath M., Snow M.H., Hall R. Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in man. Clin. Endocrinol. (Oxf.) 10: 7, 1979.

    CAS  Google Scholar 

  174. Sowers J.R., McCallum R.W., Hershman J.M., Carlson H.E., Sturdevant R.A.L., Meyer N. Comparison of metoclopramide with other dynamic tests of prolactin secretion. J. Clin. Endocrinol. Metab. 43: 679, 1976.

    PubMed  CAS  Google Scholar 

  175. Healy D.L., Burger H.G. Increased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationships. Clin. Endocrinol. (Oxf.) 7: 195, 1977.

    CAS  Google Scholar 

  176. Massara F., Camanni F., Belforte L., Vergano V., Molinatti M. Increased thyrotrophin secretion induced by sulpiride in man. Clin. Endocrinol. (Oxf.) 9: 419, 1978.

    CAS  Google Scholar 

  177. Smythe G.A., Brandstater J.F., Lazarus L. Rapid induction of prolactin secretion by 3-iodo-L-tyrosine. Neuroendocrinology 14: 362, 1974.

    PubMed  CAS  Google Scholar 

  178. Smythe G.A., Compton P.J., Lazarus L. The stimulation of human prolactin secretion by 3-iodo-L-tyrosine. J. Clin. Endocrinol. Metab. 40: 714, 1975.

    PubMed  CAS  Google Scholar 

  179. Sawin C.T., Hershman J.M. The TSH response to thyrotropin-releasing hormone (TRH) in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones. J. Clin. Endocrinol. Metab. 42: 809, 1976.

    PubMed  CAS  Google Scholar 

  180. Bakke J.L., Lawrence N. Circadian periodicity in thyroid stimulating hormone titer in the rat hypophysis and serum. Metabolism 14: 841, 1965.

    CAS  Google Scholar 

  181. Nicoloff J.T., Fisher D.A., Appleman M.D. The role of glucocorticoids in the regulation of thyroid function in man. J. Clin. Invest. 49: 1922, 1970.

    PubMed Central  PubMed  CAS  Google Scholar 

  182. Patel Y.C., Alford F.P., Burger H.G. The 24 hour plasma thyrotrophin profile. Clin. Sci. 43: 71, 1972.

    PubMed  CAS  Google Scholar 

  183. Weeke J. Circadian variation of the serum thyrotropin level in normal subjects. Scand. J. Clin. Lab. Invest. 31: 337, 1973.

    PubMed  CAS  Google Scholar 

  184. Re R.N., Kourides I.A., Ridgway E.C., Weintraub B.D., Maloof F. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J. Clin. Endocrinol. Metab. 43: 338, 1976.

    PubMed  CAS  Google Scholar 

  185. Sowers J.R., Carlson H.E., Brautbar N., Hershman J.M. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man. J. Clin. Endocrinol. Metab. 44: 237, 1977.

    PubMed  CAS  Google Scholar 

  186. Patel Y.C., Baker M.W.G., Burger H.G., Johns M.W., Ledinek J.E. Suppression of thyrotrophin circadian rhythm by glucocorticoids. J. Endocrinol. 62: 421, 1974.

    PubMed  CAS  Google Scholar 

  187. Weeke J., Laurberg P. Diurnal TSH variations in hypothyroidism. J. Clin. Endocrinol. Metab. 43: 32, 1976.

    PubMed  CAS  Google Scholar 

  188. Yoshimura M., Ochi Y., Miyazaki T., Shiomi K., Hachiya T. Effect of L-5-HTP on release of growth hormone, TSH and insulin. Endocrinol. Jpn. 20: 135, 1973.

    PubMed  CAS  Google Scholar 

  189. Ferrari C., Paracchi A., Rondena M., Beck-Peccoz P., Faglia G. Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man. Clin. Endocrinol. (Oxf.) 5: 575, 1976.

    CAS  Google Scholar 

  190. Egge A.C., Rogol A.D., Varma M.M., Blizzard R.M. Effect of cyproheptadine on TRH-stimulated prolactin and TSH release in man. J. Clin. Endocrinol. Metab. 44: 210, 1977.

    PubMed  CAS  Google Scholar 

  191. Tanjasiri P., Kozbur X., Florsheim W.H. Somatostatin in the physiologic feedback control of thyrotropin secretion. Life Sci. 19: 657, 1976.

    PubMed  CAS  Google Scholar 

  192. Arimura A., Gordin A., Schally A.V. Increase in basal and thyrotropin-releasing hormone-stimulated secretion of thyrotropin and the effects of triiodothyronine in rats passively immunized with antiserum to somatostatin. Fed. Proc. 35: 782, 1976.

    Google Scholar 

  193. Ferland L., Labrie F., Jobin M., Arimura A., Schally A.V. Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem. Biophys. Res. Commun. 68: 149, 1976.

    PubMed  CAS  Google Scholar 

  194. Lucke C., Hoffken B., Von Zur Muhlen A. The effect of somatostatin on TSH levels in patients with primary hypothyroidism. J. Clin. Endocrinol. Metab. 41: 1082, 1975.

    PubMed  CAS  Google Scholar 

  195. Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin of the release of TSH induced in man by thyrotrophin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.

    PubMed  CAS  Google Scholar 

  196. Weeke J., Prange-Hansen A., Lundbaek K. Inhibition by somatostatin of basal levels of serum thyrotropin in normal men. J. Clin. Endocrinol. Metab. 41: 168, 1975.

    PubMed  CAS  Google Scholar 

  197. MacLeod R.M., Robyn C. Mechanism of increased prolactin secretion by sulpiride. J. Endocrinol. 72: 273, 1977.

    PubMed  CAS  Google Scholar 

  198. Schally A.V., Dupont A., Arimura A., Takahara J., Redding T.W., Clemens J., Shaar C. Purification of a catecholamine-rich fraction with prolactin release inhibiting factor (PRIF) activity from porcine hypothalamus. Acta Endocrinol. (Kbh.) 82: 1, 1976.

    CAS  Google Scholar 

  199. Shaar C.J., Clemens J.A. The role of catecholamines in the release of anterior pituitary prolactin in vitro. Endocrinology 95: 1202, 1974.

    PubMed  CAS  Google Scholar 

  200. MacLeod R.M. Regulation of prolactin secretion. Frontiers in Neuroendocrinology 4: 169, 1976.

    CAS  Google Scholar 

  201. Del Pozo E., Brun Del Re R., Varga L., Friesen M.G. The inhibition of prolactin secretion in man by CB 154 (2-br-α-ergocryptine). J. Clin. Endocrinol. Metab. 35: 768, 1972.

    PubMed  CAS  Google Scholar 

  202. Del Pozo E., Friesen H., Burmeister P. Endocrine profile of a specific prolactin inhibitor: Br-Ergocryptine (CB 154). Schweiz. Med. Wochenschr. 103: 847, 1973.

    PubMed  CAS  Google Scholar 

  203. Del Pozo E., Varga L., Wyss H., Tolis G., Friesen H., Wenner R., Vetter L., Mettwiler A. Clinical and hormonal response to bromocriptine (CB 154) in the galactorrhoea syndromes. J. Clin. Endocrinol. Metab. 39: 18, 1974.

    PubMed  Google Scholar 

  204. Takahara J., Arimura A., Schally A.V. Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. Endocrinology 95: 462, 1974.

    PubMed  CAS  Google Scholar 

  205. Hokfelt T., Fuxe K. Effect of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology 4: 100, 1972.

    Google Scholar 

  206. Gudelsky G.A., Simpkins J., Mueller G.P., Meites J., Moore K.E. Selective action of prolactin on catecholamine turnover in the hypothalamus and on serum LH and FSH. Neuroendocrinology 22: 206, 1976.

    PubMed  CAS  Google Scholar 

  207. Sinha Y., Tucker H. Pituitary prolactin content and mammary development after chronic administration of prolactin. Proc. Soc. Exp. Biol. Med. 128: 84, 1968.

    PubMed  CAS  Google Scholar 

  208. Clemens J.A., Meites J. Inhibition by hypothalamic prolactin implants of prolactin secretion, mammary growth and luteal function. Endocrinology 82: 878, 1968.

    PubMed  CAS  Google Scholar 

  209. MacLeod R.M., DeWitt G.W., Smith M.C. Suppression of pituitary gland hormone content by pituitary tumour hormones. Endocrinology 82: 899, 1968.

    Google Scholar 

  210. Fuxe K., Hokfelt T. Further evidence for the existence of tubero-infundibular neurons. Acta Physiol. Scand. 66: 245, 1966.

    PubMed  CAS  Google Scholar 

  211. Fuxe K., Hokfelt T., Nilsson O. Factors involved in the control of the activity of the tubero-infundibular dopamine neurons during pregnancy and lactation. Neuroendocrinology 5: 257, 1969.

    PubMed  CAS  Google Scholar 

  212. Voogt J.L., Carr L.A. Plasma prolactin levels and hypothalamic catecholamine synthesis during suckling. Neuroendocrinology 16: 108, 1974.

    PubMed  CAS  Google Scholar 

  213. Voogt J.L., Carr L.A. Potentiation of suckling-induced release of prolactin by inhibition of brain catecholamine synthesis. Endocrinology 97: 891, 1975.

    PubMed  CAS  Google Scholar 

  214. Carr L.S., Conway P.M., Voogt J.L. Role of norepinephine in the release of prolactin induced by suckling and oestrogen. Brain Res. 133: 305, 1977.

    PubMed  CAS  Google Scholar 

  215. Mueller G.P., Franco S., Reichlin S., Jackson I.M.D. Elevated serum thyrotropin (TSH) of myxoedema does not require continuous thyrotropin releasing hormone secretion. Clin. Res. 298A: abstract, 1977.

  216. Schally A.V., Redding T.W., Arimura A., Dupont A., Linthicum G.L. Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro. Endocrinology 100: 681, 1977.

    PubMed  CAS  Google Scholar 

  217. Lamberts S.W.J., MacLeod R.M. Studies on the mechanism of theGABA-mediated inhibition of prolactin secretion. Proc. Soc. Exp. Biol. Med. 158: 10, 1978.

    PubMed  CAS  Google Scholar 

  218. Mioduszewsky R., Grandison L., Meites J. Stimulation of prolactin release in rats by GABA. Proc. Soc. Exp. Biol. Med. 151: 44, 1976.

    Google Scholar 

  219. Vale W., Rivier C., Brazeau P., Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 95: 968, 1974.

    PubMed  CAS  Google Scholar 

  220. Yen S., Siler T., DeVane G. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels. N. Engl. J. Med. 290: 935, 1974.

    PubMed  CAS  Google Scholar 

  221. Copinschi G., Leclercq-Meyer V., Virasoro E., L’Hermite M., Vanhaelst L., Golstein J., Leclercq R., Fery F., Robyn C. Pituitary and extrapituitary effects of somatostatin in normal man. Horm. Metab. Res. 8: 226, 1976.

    PubMed  CAS  Google Scholar 

  222. Hall R., Besser G.M., Schally A.V., Coy D.H., Evered D., Goldie D.J., Kastin A.J., McNeilly A.S., Mortimer C.H., Phenekos C., Tunbridge W.M.G., Weightman D. Action of growth hormone-release inhibiting hormone in healthy man and in acromegaly. Lancet 2: 581, 1973.

    PubMed  CAS  Google Scholar 

  223. Siler T.M., Vandenberg G., Yen S.S.C., Brazeau P., Vale W., Guillemin R. Inhibition of growth hormone release in humans by somatostatin. J. Clin. Endocrinol. Metab. 37: 632, 1973.

    PubMed  CAS  Google Scholar 

  224. Noel G.L., Dimond R.C., Wartofsky L., Earll J.M., Frantz A.G. Studies of prolactin and TSH secretion by continuous infusion of small amounts of thyrotrophin-releasing hormone (TRH). J. Clin. Endocrinol. Metab. 39: 6, 1974.

    PubMed  CAS  Google Scholar 

  225. Burnet F.R., Wakerley J.B. Plasma concentrations of prolactin and thyrotrophin during suckling in urethane-anaesthetised rats. J. Endocrinol. 70:429, 1976.

    PubMed  CAS  Google Scholar 

  226. Gautvik K.M., Weintraub B.D., Graeber C.T., Maloof F., Zuckerman J.E., Tashjian A.J. Serum prolactin and TSH: effects of nursing and pyro Glu-His-Prol-NH2 administration in post-partum women. J. Clin. Endocrinol. Metab. 36: 135, 1973.

    Google Scholar 

  227. Chan V., Jones A., Liendo-Ch P., McNeilly A., Landon J., Besser G.M. The relationship between circadian variations in circulating thyrotrophin, thyroid hormones and prolactin. Clin. Endocrinol. (Oxf.) 9: 337, 1978.

    CAS  Google Scholar 

  228. Lloyd H.M., Meares J.D., Jacobi J. Early effects of stilboestrol on growth hormone and prolactin secretion and on pituitary mitotic activity in the male rat. J. Endocrinol. 58: 227, 1973.

    PubMed  CAS  Google Scholar 

  229. Yen S.S.C., Ehara Y., Siler T.M. Augmentation of prolactin secretion by estrogen in hy-pogonadal women. J. Clin. Invest. 53: 652, 1974.

    PubMed Central  PubMed  CAS  Google Scholar 

  230. Gold M.S., Redmond D.E., Donabedian R.K. Prolactin secretion, a measurable central effect of opiate-receptor antagonist. Lancet 1: 323, 1975.

    Google Scholar 

  231. Guidotti A., Grandison L. Participation of hypothalamic endorphins in the control of prolactin release. Adv. Biochem. Psychopharmacol. 18: 191, 1977.

    Google Scholar 

  232. Janonsky D., Judd L., Huey L., Roitman N., Parker D. Segal D. Negative naloxone effects on serum-prolactin. Lancet 2: 637, 1978.

    Google Scholar 

  233. Dupont A., Cusan L., Garon M., Labrie F., Li C.H. β-endorphin: stimulation of growth hormone release in vivo. Proc. Nat. Acad. Sci. USA 74: 358, 1977.

    PubMed Central  PubMed  CAS  Google Scholar 

  234. Thorner M.D., Besser G.M., Jones A., Davie J., Jones A.E. Bromocriptine treatment of female infertility: report of 13 pregnancies. Br. Med. J. 4: 694, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  235. Thorner M.O., McNeilly A.S., Hagan C., Besser G.M. Long term treatment of galactorrhea and hypogonadism with Bromocriptine. Br. Med. J. 2: 419, 1974.

    PubMed Central  PubMed  CAS  Google Scholar 

  236. Quadri S.K., Meites J. Ergot-induced inhibition of pituitary tumour growth in rats. Science 176: 417, 1972.

    PubMed  CAS  Google Scholar 

  237. Davies C., Jacobi J., Lloyd H.M., Meares D.J. DNA synthesis and the secretion of prolactin and GH by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-Brom-α-ergocriptine methane sulphonate. J. Endocrinol. 61: 411, 1974.

    PubMed  CAS  Google Scholar 

  238. Lloyd H.M., Meares J.D., Jacobi J. Effects of oestrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature 255: 497, 1975.

    PubMed  CAS  Google Scholar 

  239. Corenblum B., Webster B.R., Mortimer C.B., Ezrin C. Possible anti-tumour effect of 2-bromo-ergocriptine (CB 154 Sandoz) in 2 patients with large prolactin-secreting pituitary adenomas. Clin. Res. 23: 614A, 1975.

    Google Scholar 

  240. Corenblum B. Bromocriptine in pituitary tumours. Lancet 2: 786, 1978.

    PubMed  CAS  Google Scholar 

  241. Ezrin C., Kovacs K., Horvath E. Hyperprolactinaemia, morphological and clinical considerations. Med. Clin. North Am. 62: 393, 1978.

    PubMed  CAS  Google Scholar 

  242. Von Werder K., Fahlbusch R., Landgraf R., Pickardt C.R., Rhosk H.K., Scriba P.C. Treatment of patients with prolactinomas. J. Endocrinol. Invest. 1: 47, 1978.

    PubMed  CAS  Google Scholar 

  243. Lamberts S.W.J., MacLeod R.M. The inability of bromocriptine to inhibit prolactin secretion by transplantable rat pituitary tumors: observations on the mechanism and dynamics of the autofeed back regulation of prolactin secretion. Endocrinology 104: 65, 1979.

    PubMed  CAS  Google Scholar 

  244. Fine S.A., Frohman L.A. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. J. Clin. Invest. 61: 973, 1978.

    PubMed Central  PubMed  CAS  Google Scholar 

  245. Hunt P., Kannengiesser M.H., Raynaud J.P. Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J. Pharm. Pharmacol. 26: 370, 1979.

    Google Scholar 

  246. Scanion M.F., Gomez-Pan A., Mora B., Cook D.B., Dewar J.H., Hildyard A., Weightman D.R., Evered D.C., Hall R. Effects of nomifensine, an inhibitor of endogenous catecholamine reuptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man. Br. J. Clin. Pharmacol. 4: 191S, 1977.

    Google Scholar 

  247. Muller E.E., Genazzani A.R., Murru S. Nomifensine: diagnostic test in hyperprolactinaemic states. J. Clin. Endocrinol. Metab. 47: 1352, 1978.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Unit, Department of Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK

    M. F. Scanlon, M. Pourmand, A. M. McGregor, M. D. Rodriguez-Arnao, K. Hall &  Reginald Hall

  2. Department of Experimental Endocrinology, Faculty of Medicine, University Compluterisis, Madrid, Spain

    A. Gomez-Pan

Authors
  1. M. F. Scanlon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Pourmand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. McGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. D. Rodriguez-Arnao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Gomez-Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Reginald Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scanlon, M.F., Pourmand, M., McGregor, A.M. et al. Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin. J Endocrinol Invest 2, 307–331 (1979). https://doi.org/10.1007/BF03350424

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350424

Key-words

Search

Navigation